
Weill Cornell Medicine
@weillcornell
Combining excellence & innovation in clinical care, research & education. #CareDiscoverTeach Our Social Media Policy: bit.ly/1vlHtPc
ID: 95972239
http://weill.cornell.edu 10-12-2009 20:01:50
12,12K Tweet
40,40K Takipçi
1,1K Takip Edilen

New drug combo used to treat drug-resistant tuberculosis is as effective as first-line medications for drug-sensitive TB, study suggests. Findings point to possible trimming of treatment time for drug-resistant TB, says team led by Weill Cornell Medicine Center for Global Health. bit.ly/3wkNFPM
